4.7 Article

In vivo validation and tissue sparing factor for acute damage of pencil beam scanning proton FLASH

Journal

RADIOTHERAPY AND ONCOLOGY
Volume 167, Issue -, Pages 109-115

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.radonc.2021.12.022

Keywords

FLASH; In vivo; Acute damage; Proton irradiation

Funding

  1. Novo Nordisk Foundation [NNF195A0059372]
  2. DCCC Radiotherapy - The Danish National Research Center for Radiotherapy, Danish Cancer Society [R191-A11526, R269-A15843]
  3. Danish Comprehensive Cancer Center, INSPIRE (European Union) [730983]
  4. Varian
  5. Siemens Healthineers Company

Ask authors/readers for more resources

This study validated the effectiveness of proton FLASH technology in a mouse leg model and quantified the FLASH factor through full dose response curves.
Background and purpose: Preclinical studies indicate a normal tissue sparing effect using ultra-high dose rate (FLASH) radiation with comparable tumor response. Most data so far are based on electron beams with limited utility for human treatments. This study validates the effect of proton FLASH delivered with pencil beam scanning (PBS) in a mouse leg model of acute skin damage and quantifies the normal tissue sparing factor, the FLASH factor, through full dose response curves. Materials and methods: The right hind limb of CDF1 mice was irradiated with a single fraction of proton PBS in the entrance plateau of either a 244 MeV conventional dose rate field or a 250 MeV FLASH field. In total, 301 mice were irradiated in four separate experiments, with 7-21 mice per dose point. The end-points were the level of acute moist desquamation to the skin of the foot within 25 days post irradiation. Results: The field duration and field dose rate were 61-107 s and 0.35-0.40 Gy/s for conventional dose rate and 0.35-0.73 s and 65-92 Gy/s for FLASH. Full dose response curves for five levels of acute skin damage for both conventional and FLASH dose rate revealed a distinct normal tissue sparing effect with FLASH: across all scoring levels, a 44-58% higher dose was required to give the same biological response with FLASH as compared to the conventional dose rate. Conclusions: The normal tissue sparing effect of PBS proton FLASH was validated. The FLASH factor was quantified through full dose response curves. (C) 2021 The Authors. Published by Elsevier B.V.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available